Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly EBT Margin of 21.81% for Q4 2025, down 580.0% year-over-year from 4.54% in Q4 2024, and down 13.53% quarter-over-quarter from 25.22% in Q3 2025.
Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBT Margin history runs 16 years deep, the most recent figure standing at 21.81% for Q4 2025.
- In Q4 2025, EBT Margin fell 580.0% year-over-year to 21.81%; the TTM figure through Dec 2025 stood at 24.16% (down 66.0% YoY), while the FY2025 annual figure was 24.98%, up 45.0% from the prior year.
- EBT Margin for Q4 2025 stood at 21.81%, down from 25.22% in the prior quarter.
- The five-year high for EBT Margin was 28.37% in Q2 2021, with the low at 104.78% in Q1 2023.
- The 5-year median for EBT Margin is 24.6% (2023), against an average of 17.59%.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 12761 bps in 2023, then soared 12908 bps in 2024.
- Prestige Consumer Healthcare's EBT Margin stood at 23.86% in 2021, then grew by 4 bps to 24.72% in 2022, then declined by 0 bps to 24.61% in 2023, then advanced by 12 bps to 27.61% in 2024, then declined by 21 bps to 21.81% in 2025.
- Business Quant data shows PBH's EBT Margin at 21.81% in Q4 2025, 25.22% in Q3 2025, and 24.76% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.81% |
| Sep 30, 2025 | 25.22% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 24.94% |
| Dec 31, 2024 | 27.61% |
| Sep 30, 2024 | 25.25% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | 24.30% |
| Dec 31, 2023 | 24.61% |
| Sep 30, 2023 | 24.59% |
| Jun 30, 2023 | 24.60% |
| Mar 31, 2023 | -104.78% |
| Dec 31, 2022 | 24.72% |
| Sep 30, 2022 | 23.02% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 22.84% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 21.59% |
| Jun 30, 2021 | 28.37% |
| Mar 31, 2021 | 16.98% |